Aspirin reduces the risk of head and neck cancer

Research results of scientists from Queen University published in the National Post Newspaper (Canada) on April 2 said that the use of a low-dose aspirin tablet per week helps reduce up to 22% of the risk of developing the base Head and neck cancer, especially throat cancer.

According to the researchers, although there has been evidence from the 1960s that Asprin has anti-cancer effects, when this drug can reduce the spread of cancerous tumors in mice, but It takes tens of years of research and analysis of data from the National Cancer Institute through the testing of aspirin with prostate, lung, colorectal and ovarian cancers, and Chinese scientists. New Queen has the basis to determine the effect of aspirin in reducing the risk of head and neck cancer.

Picture 1 of Aspirin reduces the risk of head and neck cancer

However, scientists also note that Aspirin is not capable of fighting all cancers associated with head and neck.

Research is still being done by scientists to accurately determine the principle of action in the body to prevent cancer of the acetylsalicylic acid component in the drug.

Previously, Dr. Nigel Carter, CEO of the British Dental Health Organization, warned that Aspirin has little effect on oral cancer, because the cause of this disease comes from smoking. too much and some other unhealthy health care habits.

According to Carter, each person should not think that using aspirin can combat the dangers of oral cancer. He said: "If a person smokes too much tobacco, drinks excessively, doesn't have a full diet and sexually transmitted skin diseases (HPV), then taking aspirin will inefficient".

Research by Queen's scientists also adds that if you use at least 75mg of aspirin every day for more than 10 years, it may reduce the risk for some other cancers such as colorectal cancer. colon and esophagus, prostate cancer and some forms of lung cancer.

According to the Canadian Ear Nose Throat Association, the country currently has about 4,300 people expected to be at risk for head or neck cancers next year and about 1,610 of them may die from the disease. .